ICF International insider to sell 2,500 shares via Morgan Stanley
Rhea-AI Filing Summary
ICF International (ICFI) submitted a Form 144 reporting a proposed sale of 2,500 common shares. The sale is to be executed through Morgan Stanley Smith Barney on 09/25/2025 on NASDAQ, with an aggregate market value of $237,125.00. The shares represent restricted stock units acquired from the issuer on 01/24/2020. There are 18,428,490 shares outstanding, so the proposed sale equals roughly 0.0136% of outstanding shares. No other securities were reported sold in the past three months and no donor/gift information is provided.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small insider sale reported; not material to company capitalization.
The filing discloses a planned sale of 2,500 common shares valued at $237,125 through a major brokerage. Given total outstanding shares of 18,428,490, the transaction is immaterial to market capitalization and unlikely to affect stock liquidity or valuation. The shares were originally issued as restricted stock units in 2020, indicating routine vesting and subsequent disposition rather than extraordinary insider action. No recent sales in the prior three months are reported, which suggests this is an isolated disposition.
TL;DR: Disclosure meets Rule 144 form requirements; represents routine compliance by an insider.
The Form 144 provides required broker, share count, acquisition date and nature (RSUs), and planned sale date consistent with Rule 144 reporting. The signer’s representation about lack of material nonpublic information is included. There are no indications of coordinated multiple disposals or patterns that would raise governance concerns. Documentation appears administrative and compliant with standard insider-sale procedures.